Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells

被引:47
作者
Henderson, JE
Naski, MC
Aarts, MM
Wang, DS
Cheng, L
Goltzman, D
Ornitz, DM
机构
[1] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Div Enoderinol & Geriat, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[4] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ, Canada
关键词
FGFR3(ACh); chondrocyte; proliferation; apoptosis; maturation; integrins;
D O I
10.1359/jbmr.2000.15.1.155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A G380R substitution in the transmembrane-spanning region of FGFR3 (FGFR3(Ach)) results in constitutive receptor kinase activity and is the most common cause of achondroplastic dwarfism in humans. The epiphyseal growth plates of affected individuals are disorganized and hypocellular and show aberrant chondrocyte maturation. To examine the molecular basis of these abnormalities, we used a chondrocytic cell line, CFK2, to stably express the b variant of wild-type FGFR3 or the the constitutively active FGFR3(Ach). Overexpression of FGFR3 had minimal effects on CFK2 proliferation and maturation compared with the severe growth retardation found in cells expressing FGFR3(Ach). Cells expressing the mutant receptor also showed an abnormal apoptotic response to serum deprivation and failed to undergo differentiation under appropriate culture conditions. These changes were associated with altered expression of integrin subunits, which effectively led to a switch in substrate preference of the immature cell from fibronectin to type II collagen. These in vitro observations support those from in vivo studies indicating that FGFR3 mediates an inhibitory influence on chondrocyte proliferation. We now suggest that the mechanism is related to altered integrin expression.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 48 条
[1]   Parathyroid hormone-related protein interacts with RNA [J].
Aarts, MM ;
Levy, D ;
He, B ;
Stregger, S ;
Chen, TP ;
Richard, S ;
Henderson, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4832-4838
[2]   Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development [J].
Amizuka, N ;
Karaplis, AC ;
Henderson, JE ;
Warshawsky, H ;
Lipman, ML ;
Matsuki, Y ;
Ejiri, S ;
Tanaka, M ;
Izumi, N ;
Ozawa, H ;
Goltzman, D .
DEVELOPMENTAL BIOLOGY, 1996, 175 (01) :166-176
[3]   PARATHYROID HORMONE-RELATED PEPTIDE-DEPLETED MICE SHOW ABNORMAL EPIPHYSEAL CARTILAGE DEVELOPMENT ALTERED ENDOCHONDRAL BONE-FORMATION [J].
AMIZUKA, N ;
WARSHAWSKY, H ;
HENDERSON, JE ;
GOLTZMAN, D ;
KARAPLIS, AC .
JOURNAL OF CELL BIOLOGY, 1994, 126 (06) :1611-1623
[4]   Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion [J].
Amizuka, N ;
Henderson, JE ;
Hoshi, K ;
Warshawsky, H ;
Ozawa, H ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 1996, 137 (11) :5055-5067
[5]  
BERNIER SM, 1993, J BONE MINER RES, V8, P475
[6]   ESTABLISHMENT OF AN OSSEOUS CELL-LINE FROM FETAL-RAT CALVARIA USING AN IMMUNOCYTOLYTIC METHOD OF CELL SELECTION - CHARACTERIZATION OF THE CELL-LINE AND OF DERIVED CLONES [J].
BERNIER, SM ;
DESJARDINS, J ;
SULLIVAN, AK ;
GOLTZMAN, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (02) :274-285
[7]  
Bonaventure J, 1996, AM J MED GENET, V63, P148, DOI 10.1002/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO
[8]  
2-N
[9]   DIFFERENTIAL ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE IN RESPONSE TO BASIC FIBROBLAST GROWTH-FACTOR IN SKELETAL-MUSCLE CELLS [J].
CAMPBELL, JS ;
WENDEROTH, MP ;
HAUSCHKA, SD ;
KREBS, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :870-874
[10]   Isolation, cloning, and sequence analysis of the integrin subunit α10, a β1-associated collages binding integrin expressed on chondrocytes [J].
Camper, L ;
Hellman, U ;
Lundgren-Åkerlund, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20383-20389